Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Independent Bank Corp
IBCP
$850M
| $4.91M | ﹤0.01% |
147,415
-12,562
| -8% | -$432K |
|
2327
Tronox
TROX
$952M
| $4.89M | ﹤0.01% |
500,461
+3,225
| +0.6% | +$22.4K |
|
2328
Sturm, Ruger & Co
RGR
$602M
| $4.88M | ﹤0.01% |
121,796
-2,354
| -2% | -$89.4K |
|
2329
Washington Trust Bancorp
WASH
$767M
| $4.88M | ﹤0.01% |
145,805
-2,571
| -2% | -$84.7K |
|
2330
Vanguard Russell 2000 ETF
VTWO
$17.6B
| $4.84M | ﹤0.01% |
48,351
-2,941
| -6% | -$307K |
|
|
HTBK
2331
DELISTED
Heritage Commerce
HTBK
| $4.84M | ﹤0.01% |
387,771
+8,607
| +2% | +$109K |
|
2332
FirstService
FSV
$6.18B
| $4.83M | ﹤0.01% |
34,798
-1,966
| -5% | -$299K |
|
2333
Trupanion
TRUP
$1.34B
| $4.83M | ﹤0.01% |
188,713
-7,355
| -4% | -$220K |
|
2334
Goldman Sachs Access US Aggregate Bond ETF
GCOR
$807M
| $4.82M | ﹤0.01% |
116,683
+9,610
| +9% | +$400K |
|
2335
Peloton Interactive
PTON
$2.47B
| $4.81M | ﹤0.01% |
1,120,591
-23,905
| -2% | -$117K |
|
2336
Lloyds Banking Group
LYG
$90.1B
| $4.8M | ﹤0.01% |
953,414
-692,552
| -42% | -$3.8M |
|
2337
iShares Dow Jones US ETF
IYY
$3.09B
| $4.79M | ﹤0.01% |
30,227
-1,437
| -5% | -$238K |
|
2338
Xencor
XNCR
$1.74B
| $4.78M | ﹤0.01% |
395,941
-14,709
| -4% | -$183K |
|
2339
Amphastar Pharmaceuticals
AMPH
$889M
| $4.76M | ﹤0.01% |
243,226
-15,835
| -6% | -$387K |
|
2340
Scansource
SCSC
$1.08B
| $4.76M | ﹤0.01% |
131,250
-5,234
| -4% | -$200K |
|
2341
iShares USD Green Bond ETF
BGRN
$502M
| $4.75M | ﹤0.01% |
100,108
+2,352
| +2% | +$113K |
|
2342
Marcus Corp
MCS
$925M
| $4.74M | ﹤0.01% |
276,236
-21,280
| -7% | -$340K |
|
2343
Quanex
NX
$962M
| $4.74M | ﹤0.01% |
263,630
-11,220
| -4% | -$212K |
|
2344
Enliven Therapeutics
ELVN
$4.31B
| $4.71M | ﹤0.01% |
120,057
+9,488
| +9% | +$263K |
|
2345
AB InBev
BUD
$157B
| $4.7M | ﹤0.01% |
67,750
+9,305
| +16% | +$672K |
|
2346
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $4.69M | ﹤0.01% |
32,010
-6,540
| -17% | -$1.01M |
|
2347
Horizon Bancorp
HBNC
$1.06B
| $4.68M | ﹤0.01% |
282,610
-1,618
| -0.6% | -$27.7K |
|
2348
Covenant Logistics
CVLG
$886M
| $4.68M | ﹤0.01% |
172,454
-3,594
| -2% | -$96.6K |
|
2349
Mercantile Bank Corp
MBWM
$1.06B
| $4.68M | ﹤0.01% |
92,659
-182
| -0.2% | -$9.35K |
|
2350
Stoke Therapeutics
STOK
$2.02B
| $4.67M | ﹤0.01% |
143,407
+2,605
| +2% | +$85.4K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.